Latest News

Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their tumors and increased blood flow within tumors survived significantly longer than did patients in whom cediranib did not increase blood flow.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • High-dose opioid prescribing continues to climb in Canada

  • Sleep disorders widely undiagnosed in individuals with multiple sclerosis

  • Unemployment for doctoral scientists, engineers below American national average in 2013

  • Mindfulness protects adults' health from the impacts of childhood adversity

  • Epilepsy breakthrough may lead to non-pharmacological therapies

  • To curb violent tendencies, start young

  • Young women involve parent in abortion when anticipating support

  • Everyday discrimination impacts mental health

  • This is your brain on snacks: Brain stimulation affects craving, consumption

  • Largest ever study of awareness during general anesthesia identifies risk factors and consequences

  •